Maulik Nanavaty - Dec 16, 2024 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Director
Signature
Svai Sanford. Attorney-in-Fact for Maulik Nanavaty
Stock symbol
RANI
Transactions as of
Dec 16, 2024
Transactions value $
$0
Form type
4
Date filed
12/17/2024, 05:00 PM
Previous filing
May 30, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options.
F2 The shares subject to the option vested as follows: 1/36th of the shares subject to the option vested monthly over three years from June 17, 2021.
F3 On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options.